[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 54, "title": "CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 894300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 44, "title": "CFO, Head of Corporate Strategy & Secretary", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 465615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 58, "title": "Executive VP, Chief Medical Officer and Head of R&D", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 671387, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski CPA", "age": 35, "title": "Corporate Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lindsay  Young", "title": "Head of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.01, "open": 10.15, "dayLow": 10.05, "dayHigh": 10.34, "regularMarketPreviousClose": 10.01, "regularMarketOpen": 10.15, "regularMarketDayLow": 10.05, "regularMarketDayHigh": 10.34, "payoutRatio": 0.0, "beta": -2.291, "forwardPE": -7.34058, "volume": 46523, "regularMarketVolume": 46523, "averageVolume": 78195, "averageVolume10days": 48530, "averageDailyVolume10Day": 48530, "bid": 9.99, "ask": 10.23, "bidSize": 1, "askSize": 1, "marketCap": 44978832, "fiftyTwoWeekLow": 5.356, "fiftyTwoWeekHigh": 20.67, "fiftyDayAverage": 8.7667, "twoHundredDayAverage": 9.194555, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 39361832, "profitMargins": 0.0, "floatShares": 3887228, "sharesOutstanding": 4440161, "sharesShort": 181847, "sharesShortPriorMonth": 216181, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.040999997, "heldPercentInsiders": 0.0011, "heldPercentInstitutions": 0.18868, "shortRatio": 2.17, "shortPercentOfFloat": 0.040999997, "impliedSharesOutstanding": 4440161, "bookValue": 2.204, "priceToBook": 4.596189, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -43099000, "trailingEps": -14.52, "forwardEps": -1.38, "lastSplitFactor": "1:13", "lastSplitDate": 1744156800, "enterpriseToEbitda": -0.913, "52WeekChange": -0.40059173, "SandP52WeekChange": 0.1653893, "quoteType": "EQUITY", "currentPrice": 10.13, "recommendationKey": "none", "totalCash": 14280000, "totalCashPerShare": 3.216, "ebitda": -43091000, "totalDebt": 8663000, "quickRatio": 2.0, "currentRatio": 2.115, "debtToEquity": 88.552, "returnOnAssets": -0.81338996, "returnOnEquity": -3.22573, "freeCashflow": -21523876, "operatingCashflow": -36798000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TPST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekLowChange": 4.774, "fiftyTwoWeekLowChangePercent": 0.89133686, "fiftyTwoWeekRange": "5.356 - 20.67", "fiftyTwoWeekHighChange": -10.54, "fiftyTwoWeekHighChangePercent": -0.50991774, "fiftyTwoWeekChangePercent": -40.059174, "dividendDate": 1544400000, "earningsTimestampStart": 1762977600, "earningsTimestampEnd": 1762977600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -14.52, "epsForward": -1.38, "epsCurrentYear": -12.78, "priceEpsCurrentYear": -0.7926448, "marketState": "CLOSED", "shortName": "Tempest Therapeutics, Inc.", "longName": "Tempest Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1758325268, "regularMarketTime": 1758312001, "exchange": "NCM", "messageBoardId": "finmb_552715229", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.1988, "regularMarketPrice": 10.13, "fiftyDayAverageChange": 1.3633003, "fiftyDayAverageChangePercent": 0.15550895, "twoHundredDayAverageChange": 0.93544483, "twoHundredDayAverageChangePercent": 0.101739, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1352730600000, "postMarketChangePercent": 0.987161, "postMarketPrice": 10.23, "postMarketChange": 0.0999994, "regularMarketChange": 0.12, "regularMarketDayRange": "10.05 - 10.34", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 78195, "displayName": "Tempest Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-20"}]